Abstract:Background: Although the diagnosis and treatment of glioblastoma (GBM) is significantly improved with recent progresses, there is still a large heterogeneity in therapeutic effects and overall survival. The aim of this study is to analyze gene expressions of transcription factors (TFs) in GBM so as to discover new tumor markers. Methods: Differentially expressed TFs are identified by data mining using public databases. The GBM transcriptome profile is downloaded from The Cancer Genome Atlas (TCGA). The nonnegative matrix factorization (NMF) method is used to cluster the differentially expressed genes to discover hub genes and signal pathways. The TFs affecting the prognosis of GBM are screened by univariate and multivariate COX regression analysis, and the receiver operating characteristic (ROC) curve is determined. The GBM hazard model and nomogram map are constructed by integrating the clinical data. Finally, the TFs involving potential signaling pathways in GBM are screened by Gene Set Enrichment Analysis (GSEA), Gene Ontology (GO), and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. Results: There are 68 differentially expressed TFs in GBM, of which 43 genes are upregulated and 25 genes are downregulated. NMF clustering analysis suggested that GBM patients are divided into three groups: Clusters A, B, and C. LHX2, MEOX2, SNAI2, and ZNF22 are identified from the above differential genes by univariate/multivariate regression analysis. The risk score of those four genes are calculated based on the beta coefficient of each gene, and we found that the predictive ability of the risk score gradually increased with the prolonged predicted termination time by time-dependent ROC curve analysis. The nomogram results have showed that the integration of risk score, age, gender, chemotherapy, radiotherapy, and 1p/19q can further improve predictive ability towards the survival of GBM. The pathways in cancer, phosphoinositide 3-kinases (PI3K)-Akt signaling, Hippo signaling, and proteoglycans, are highly enriched in high-risk groups by GSEA. These genes are mainly involved in cell migration, cell adhesion, epithelial-mesenchymal transition (EMT), cell cycle, and other signaling pathways by GO and KEGG analysis. Conclusion: The four-factor combined scoring model of LHX2, MEOX2, SNAI2, and ZNF22 can precisely predict the prognosis of patients with GBM.

Application of Deep Learning-based Fuzzy Systems to Analyze the Overall Risk of Mortality in Glioblastoma Multiforme

Overall mortality risk analysis for rectal cancer using deep learning-based fuzzy systems

Applications of Deep Learning and Fuzzy Systems to Detect Cancer Mortality in Next-Generation Genomic Data

A Machine Learning‐based Survival Prediction Model of High Grade Glioma by Integration of Clinical and Dose‐volume Histogram Parameters

Identification and validation of a novel robust glioblastoma prognosis model based on bioinformatics

Multimodal Data Integration Using Deep Learning Predicts Overall Survival of Patients with Glioma

Identification of WHO II/III Gliomas by 16 Prognostic-related Gene Signatures using Machine Learning Methods

Bios-06. Machine Learning Model Independently Identifies Clinical Features Associated With Wild-Type Glioblastoma Versus Mutant Grade 4 Astrocytoma

An Interpretable Web-based Glioblastoma Multiforme Prognosis Prediction Tool using Random Forest Model

A hierarchical machine learning model based on Glioblastoma patients' clinical, biomedical, and image data to analyze their treatment plans

A Novel Multi-Omics Analysis Model for Diagnosis and Survival Prediction of Lower-Grade Glioma Patients

An online survival predictor in glioma patients using machine learning based on WHO CNS5 data

Improve Glioblastoma Multiforme Prognosis Prediction by Using Feature Selection and Multiple Kernel Learning

Comparison of MRI Radiomics-Based Machine Learning Survival Models in Predicting Prognosis of Glioblastoma Multiforme

Radiogenomics-Based Risk Prediction of Glioblastoma Multiforme with Clinical Relevance

NIMG-60. PREDICTING OVERALL SURVIVAL IN GLIOBLASTOMA USING HISTOPATHOLOGY VIA AN END-TO-END DEEP LEARNING PIPELINE: A LARGE MULTI-COHORT STUDY

A Deep Learning Model with Radiomics Analysis Integration for Glioblastoma Post-Resection Survival Prediction

Development of a web-based tool for estimating individualized survival curves in glioblastoma using clinical, mRNA, and tumor microenvironment features with fusion techniques

A Novel Prognostic Signature of Transcription Factors for the Prediction in Patients with GBM.

Machine learning algorithms for predicting glioma patient prognosis based on CD163+FPR3+ macrophage signature

Whole-Genome Multi-omic Study of Survival in Patients with Glioblastoma Multiforme